Upon completion of the video presentation, to finish the activity and claim your credit, please click
here.
This activity has expired, credit is no longer available.
Supported by unrestricted educational grants from Astellas Pharma Global Development, Inc. and Jazz Pharmaceuticals.
A Deeper Dive into Advanced and Future Directions in Treating Patients with Acute Myeloid Leukemia
Sandra E. Kurtin, PhDc, ANP-C, AOCN®
The University of Arizona Cancer Center
Gabrielle Zecha, PA-C
The University of Washington
Hear from expert advanced practitioners about the updated WHO classification criteria and today’s leading-edge treatments for AML. Also learn about the molecular mutations commonly associated with this disease and how to identify patients who are genetically predisposed.
These CME/CE/CPE accredited activities are jointly provided by
